Effect of denosumab on osteolytic lesion activity after total hip arthroplasty: a single-centre, randomised, double-blind, placebo-controlled, proof of concept trial

Mohit M. Mahatma, Raveen L. Jayasuriya, David Hughes, Nigel Hoggard, Simon C. Buckley, Andrew Gordon, Andrew J. Hamer, Mohammed W. Tomouk, Robert M. Kerry, Richard Eastell, Jeremy M. Wilkinson*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    6 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)e195-e203
    JournalThe Lancet Rheumatology
    Volume3
    Issue number3
    DOIs
    Publication statusPublished (VoR) - Mar 2021

    Fingerprint

    Dive into the research topics of 'Effect of denosumab on osteolytic lesion activity after total hip arthroplasty: a single-centre, randomised, double-blind, placebo-controlled, proof of concept trial'. Together they form a unique fingerprint.

    Cite this